Politiparty
Politiparty
LeaderboardCongressBills

119th Congress Crime and Law Enforcement

H.R. 1266: Combating Illicit Xylazine Act

Passed HouseSep 15, 2026

  1. Introduced (completed)Feb 12, 2025
  2. Passed House (completed)Sep 15, 2026
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Feb 12, 2025

This bill regulates xylazine under the Controlled Substances Act (CSA).

Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.

This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused.

Read the full summary

Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA.

The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs.

The bill also exempts xylazine manufacturers from the CSA's physical security requirements.

Finally, the bill requires the DEA, in coordination with the Food and Drug Administration, to report on (1) the prevalence and impact of illicit xylazine use in the United States, and (2) updated information on the prevalence and proliferation of xylazine trafficking and misuse in the United States.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

114

Bipartisan support.

Who scored on this bill

566 points earned
  1. 1Jimmy Panetta D-CA SponsorDrew cross-party cosponsors, reached a cosponsor milestone, introduced, marked up, reported, discharged, passed House9 events+110
  2. 2Mark Alford R-MOCosponsored; cosponsored bill passed2 events+4
  3. 2Jake Auchincloss D-MACosponsored; cosponsored bill passed2 events+4
  4. 2Don Bacon R-NECosponsored; cosponsored bill passed2 events+4
  5. 2James Baird R-INCosponsored; cosponsored bill passed2 events+4
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Jimmy Panetta

History

  1. Sep 15, 2026Passed the House by voice vote.
  2. Feb 12, 2025Introduced in the House by Jimmy Panetta.
Show the full action history (20 actions)
  1. Sep 16, 2026Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.
  2. Sep 15, 2026Considered under suspension of the rules. (consideration: CR H5671-5673)
  3. Sep 15, 2026On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5671-5672)
  4. Sep 15, 2026Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
  5. Sep 15, 2026Considered under suspension of the rules.
  6. Sep 15, 2026DEBATE - The House proceeded with forty minutes of debate on H.R. 1266.
  7. Sep 15, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  8. Sep 15, 2026On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  9. Sep 15, 2026Motion to reconsider laid on the table Agreed to without objection.
  10. Sep 14, 2026Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
  11. Sep 14, 2026Committee on the Judiciary discharged.
  12. Sep 14, 2026Placed on the Union Calendar, Calendar No. 715.
  13. Jul 21, 2026Committee Consideration and Mark-up Session Held
  14. Jul 21, 2026Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 48 - 0.
  15. Jul 20, 2026Committee Consideration and Mark-up Session Held
  16. Jun 25, 2026Subcommittee Consideration and Mark-up Session Held
  17. Jun 25, 2026Forwarded by Subcommittee to Full Committee by Voice Vote.
  18. Feb 12, 2025Referred to the Subcommittee on Health.
  19. Feb 12, 2025Introduced in House
  20. Feb 12, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.